(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics >  Cancer
 
 Cancer Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  3  4  5  6  7  8  9  10  11  12  Next »
2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is Venture Planning Group’s new study of the major business opportunities emerging in the French cancer diagnostics market during the next five years....


 

$6700.00
       
2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, and Physician Offices” is Venture Planning Group’s new study of the major business opportunities emerging in the German cancer diagnostics market during the next five years....


 

$6700.00
       
2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is Venture Planning Group’s new study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years....


 

$6700.00
       
2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is Venture Planning Group’s new study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years....


 

$6700.00
       
2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is Venture Planning Group’s new study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years....


 

$6700.00
       
Future Horizons and Growth Strategies in the French Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
Future Horizons and Growth Strategies in the German Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
Future Horizons and Growth Strategies in the Italian Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
Future Horizons and Growth Strategies in the Spanish Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
Future Horizons and Growth Strategies in the UK Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
2014-2018 French Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

“2014-2018 French Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
2014-2018 German Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

“2014-2018 German Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
2014-2018 Italian Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

“2014-2018 Italian Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
2014-2018 Spanish Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

“2014-2018 Spanish Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
2014-2018 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

“2014-2018 UK Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$6700.00
       
2014 Analysis of the US Hospital Cancer Diagnostics Market

This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including:

Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years.


 

$6500.00
       
2015 US Hospital Cancer Diagnostics Market

This new report from VPGMarketResearch.com contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including:



 

$6500.00
       
US Hospital Cancer Diagnostics Market 2014

This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: 

  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years. 
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$6500.00
       
« Previous     3  4  5  6  7  8  9  10  11  12   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X